Aleksandra Kukla, M.D.

  1. Nephrologist

Publications

  1. Singh P, Razonable RR, Lorenz EC, DiCaudo DJ, Sukov WR, Bridges AG, Alkhateeb HB, Hogan WJ, Klomjit N, Thirunavukkarasu S, Amer H, Kudva YC, Khamash H, Stegall M, Kukla A. Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity. Am J Transplant. 2021 Feb; 21 (2):883-888 Epub 2020 Sept 20
    View PubMed
  2. Kukla A, Alexander MP, Turkevi-Nagy S, Merzkani M, Park W, Smith B, Zhang P, Benavides X, D'Costa M, Morales Alvarez C, Denic A, Bentall A, Kudva YC, Stegall M. Mesangial expansion at 5 years predicts death and death-censored graft loss after renal transplantation. Clin Transplant. 2021 Jan; 35 (1):e14147 Epub 2020 Nov 24
    View PubMed
  3. Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD, Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int. 2020 Dec 24 [Epub ahead of print]
    View PubMed
  4. Owoyemi I, Vaughan LE, Costello CM, Thongprayoon C, Markovic SN, Herrmann J, Otley CC, Taner T, Mangold AR, Leung N, Herrmann SM, Kukla A. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis. Cancer. 2020 Nov 1; 126 (21):4780-4787 Epub 2020 Aug 12
    View PubMed
  5. Phadke G, Kaushal A, Tolan DR, Hahn K, Jensen T, Bjornstad P, Roncal-Jimenez C, Hernando AA, Lanaspa MA, Alexander MP, Kukla A, Johnson RJ. Osmotic Nephrosis and Acute Kidney Injury Associated With SGLT2 Inhibitor Use: A Case Report. Am J Kidney Dis. 2020 Jul; 76 (1):144-147 Epub 2020 May 05
    View PubMed
  6. Kukla A, Hill J, Merzkani M, Bentall A, Lorenz EC, Park WD, D'Costa M, Kudva YC, Stegall MD, Shah P. The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients. Transplant Direct. 2020 Feb; 6 (2):e524 Epub 2020 Jan 13
    View PubMed
  7. Issa N, Sanchez OA, Kukla A, Riad SM, Berglund DM, Ibrahim HN, Matas AJ. Weight gain after kidney donation: Association with increased risks of type 2 diabetes and hypertension. Clin Transplant. 2018 Sep; 32 (9):e13360 Epub 2018 Aug 18
    View PubMed
  8. Dean PG, Kukla A, Stegall MD, Kudva YC. Pancreas transplantation. BMJ. 2017 Apr 3; 357:j1321 Epub 2017 Apr 03
    View PubMed
  9. Serrano OK, Kandaswamy R, Gillingham K, Chinnakotla S, Dunn TB, Finger E, Payne W, Ibrahim H, Kukla A, Spong R, Issa N, Pruett TL, Matas A. Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes from the University of Minnesota. Transplantation. 2017 Apr 03;
    View PubMed
  10. Sheta M, Riad S, Deepak U, Issa N, Birkenbach M, Ibrahim HN, Kukla A. Costimulation pathway blockade in kidney transplant recipients with de-novo rheumatoid arthritis. Clin Nephrol Case Stud. 2017; 5:16-19 Epub 2017 Feb 17
    View PubMed
  11. Tower CM, Reyes M, Nelson K, Leca N, Kieran N, Muczynski K, Jefferson JA, Blosser C, Kukla A, Maurer D, Chandler W, Najafian B. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-mediated Rejection. Transplantation. 2016 Nov 15;
    View PubMed
  12. Krichner, V, Funger, E Finger, E, Bellin, M, Dunn, TB Dunn TB, Gruessner R, Herring B, Humar, A, Kukla A, Matas, AJ, Pruett, TL, Sutherland DE, Kandaswamy R. Long-term Outcomes for Living Pancreas Donors in the Modern Era. Transplantation .
    View PubMed
  13. Ibrahim HN, Foley RN, Reule SA, Spong R, Kukla A, Issa N, Berglund DM, Sieger GK, Matas AJ. Renal Function Profile in White Kidney Donors: The First 4 Decades. J Am Soc Nephrol. 2016 Feb 17;
    View PubMed
  14. Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder. Clin Transplant. 2016 Jan; 30: (1)60-5.
    View PubMed
  15. Issa N, Kukla A, Jackson S, Riad SM, Foster MC, Matas AJ, Eckfeldt JH, Ibrahim HN. Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation. Transplantation. 2014 Oct 27; 98: (8)871-7.
    View PubMed
  16. Kukla A, Radosevich D, Finger E, Kandaswamy K. High urine amylase level and the risk of enteric conversion in solitary pancreas transplant recipients Transplantation Proceedings.2014;46(6):1938-41.
  17. MacDonald D, Kukla AK, Ake S, Berglund D, Jackson S, Issa N, Spong R, Matas AJ, Ibrahim HN. Medical outcomes of adolescent live kidney donors. Pediatr Transplant. 2014 Jun; 18: (4)336-41.
    View PubMed
  18. Berglund D, MacDonald D, Jackson S, Spong R, Issa N, Kukla A, Reule S, Weber M, Matas AJ, Ibrahim HN. Low birthweight and risk of albuminuria in living kidney donors. Clin Transplant. 2014 Mar; 28: (3)361-7.
    View PubMed
  19. Issa N, Ortiz F, Reule SA, Kukla A, Kasiske BL, Mauer M, Jackson S, Matas AJ, Ibrahim HN, Najafian B. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure. Kidney Int. 2014 Feb; 85: (2)404-15.
    View PubMed
  20. Kukla A, Issa N, Jackson S, Spong R, Foster MC, Matas AJ, Mauer MS, Eckfeldt JH, Ibrahim HN. Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients. Am J Nephrol. 2014; 39: (1)59-65.
    View PubMed
  21. Issa N, Kukla A. Peritoneal dialysis immediately after kidney transplantation. Adv Perit Dial. 2014; 30:83-6.
    View PubMed
  22. Faravardeh A, Eickhoff M, Jackson S, Spong R, Kukla A, Issa N, Matas AJ, Ibrahim HN. Predictors of graft failure and death in elderly kidney transplant recipients. Transplantation. 2013 Dec 27; 96: (12)1089-96.
    View PubMed
  23. Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol. 2013; 37: (6)602-12.
    View PubMed
  24. Issa N, Kukla A, Ibrahim HN. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol. 2012 Jun; 10: (2)169-74.
    View PubMed
  25. Kukla A, Issa N, Ibrahim HN. Pregnancy in renal transplantation: Recipient and donor aspects in the Arab world. Arab J Urol. 2012 Jun; 10: (2)175-81.
    View PubMed
  26. Rizzari M, Suszynski T, Gillingham k, Dunn T, Ibrahim HN, Payne W, Chinnakotla S, Finger E, Sutherland D, Kandaswamy R, Najarian J, Pruett T, Kukla A, Spong R, Matas AJ. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation Clinical Journal of the American Society of Nephrology.2012;7(3):494-503.
  27. Issa N, Lankireddy S, Kukla A. Should peritoneal dialysis be the preferred therapy pre-kidney transplantation? Adv Perit Dial. 2012; 28:89-93.
    View PubMed
  28. Kukla A, Chen E, Spong R, Weber M, El-Shahawi Y, Gillingham K, Matas AJ, Ibrahim HN. Recurrent glomerulonephritis under rapid discontinuation of steroids Transplantation.2011;91(12):1386-1390.
  29. Kasiske B, Kukla A, Thomas D, Wood Ives J, Snyder J, Qiu T, Peng Y, Dharnidharka V, Israni A. Lymphoproliferative disorders after adult kidney transplant; epidemiology and comparison of registry report with claims-based diagnosis American Journal of Kidney Disease.2011;58(6):971-980.
  30. Ibrahim HN, Kukla A, Cordner G, Bailey R, Gillingham K, Matas AJ. Diabetes after kidney donation American Journal of Transplantation .2010;10(2):331-337.
  31. Kukla A, El-Shahawi Y, Leister E, Kasiske B, Mauer M, Matas M, Ibrahim HN. GFR-estimating models in kidney transplant recipients on a steroid-free regimen Nephrology Dialysis Transplantation.2010;25(5):1653-1661.
  32. Kukla A, Sebasky , M, Akkina S, Leister E, Hongfei G, Matas A, Ibrahim HN. Appraisal of GFR estimating equations following kidney disease American Journal of Kidney Disease.2009;53(6):1050-1058.
  33. Kukla A, Ibrahim HN. Current concepts of chronic kidney disease classification and screening US Nephrology .2009;4(1):19-21.
  34. Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, Djamali A. CKD stage-to-stage progression in native and transplant kidney disease Nephrology Dialysis Transplantation .2008;23(2):1050-1058.
PST-20241279